Dr. John P. Nardandrea Jr., MD

Dr. Nardandrea practices at Ocala Health Primary Care LLC in Ocala, Florida.

Dr. Nardandrea's NPI, 1871572016, was assigned on January 16, 2006. Dr. Nardandrea graduated from University Of Florida College Of Medicine in 1985. Dr. Nardandrea holds Florida license ME48863.

Dr. Nardandrea's primary practice is Ocala Health Primary Care LLC, at 2415 Se 17th St, Ocala, FL 34471 in Marion County. The practice phone is (850) 267-1040.

Dr. Nardandrea's primary practice is Ocala Health Primary Care LLC in Ocala, Florida. The medical group on file is HCA Florida Ocala Primary Care. Dmand AI also links Dr. Nardandrea to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nardandrea practices. Vendor and product names are available with a free account.

Family medicine is Dr. Nardandrea's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Nardandrea is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Nardandrea's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists acid reflux, acute mini-stroke (TIA), acute sinusitis, acute skin infection, aneurysm, anxiety, arthritis and asthma among the conditions Dr. Nardandrea treats.

CMS data shows 4,432 Medicare services from Dr. Nardandrea across 33 procedure codes in 2024, for 312 Medicare patients. Medicare paid $77,124 for them. Every service was in an office.

CMS counts 312 Medicare patients who saw Dr. Nardandrea in 2024. The largest group is 65 to 74, with 152 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 0.81, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nardandrea's median patient age at 71, with 41% women.

In 2024, Dr. Nardandrea wrote 8,060 Medicare Part D claims for 490 patients. 91% of them were for generic drugs. CMS names the drug for 7,620 of them, across 120 drugs with 11 or more claims each, at $444,901 in total drug cost. In 2023, CMS named 7,656 claims across 115 drugs.

Dmand AI links Dr. Nardandrea to 5 clinical trials. 1 is still active or recruiting. Conditions studied include Prediabetic State, Obesity and Alzheimer Disease. Eli Lilly and Company sponsors the most, 5. Open Payments lists research payments to Dr. Nardandrea that name 6 trials.

CMS Open Payments shows 689 general payments to Dr. Nardandrea from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Eli Lilly and Company paid the most, $5,896. It also lists 18 research payments totaling $111,785 from 2016 to 2025, naming 6 clinical trials.

Dmand AI lists 1 award for Dr. Nardandrea, most recently NCQA PCMH in 2016.

Dr. Nardandrea graduated from University Of Florida College Of Medicine in 1985.

Dr. Nardandrea is in network with 16 carriers, including Blue Cross Blue Shield of Michigan, HCSC and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.